Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products
WITHDRAWN  

Product information

Amonafide L-malate

EU orphan designation number: EU/3/07/483
Active ingredient: Amonafide L-malate
Indication: Treatment of acute myeloid leukaemia
Sponsor: Antisoma Research Ltd
Chiswick Park Building 5, 566 Chiswick High Road, London W4 5YF, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2007 Centralised Orphan - Designation EMEA/OD/069/07 (2007)5244 of 22/10/2007
09/01/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/069/07/T/01 (2009)16 of 05/01/2009
11/03/2011 Centralised Orphan - Removal of orphan designation from Community Register